Funding for this research was provided by:
Novo Nordisk Fonden (NNF18OC0052064)
Article History
Received: 11 May 2021
Accepted: 19 January 2022
First Online: 26 January 2022
Declarations
:
: Not applicable as it is a registry-based study.
: Not applicable.
: Not applicable.
: BL received research grants to her institution from Amgen and Novo Nordisk. BL has received honoraria for advisory board and/or lectures from UCB, Amgen, Eli Lilly, Gedeon-Richter, and Gilead. The other authors declare no competing interests.